Search Results - erlotinib

1 Results

Sort By:

Carrier-Free Curcumin Nanoparticle for EGFR Positive Cancer Therapy

Reference #: 01472 The University of South Carolina is offering licensing opportunities for Carrier-free curcumin nanoparticle for EGFR positive cancer therapy Background: Due to their small size and large surface area, drug nanoparticles show great promise in improving drug delivery in patients. Invention Description: Most nanoparticle based...

Published: 2/1/2024 | Inventor(s): Peisheng Xu

Keywords(s): cancer, carrier-free, curcumin, EGFR receptor, erlotinib, nanoparticle, Nanotechnology

Category(s): Health Sciences, Biomedical and Life Sciences, Nanotechnology